CSF3 and neutropenia: For example, whether the effects of G-CSF as a treatment for chemotherapy-induced neutropenia among cancer patients, and of hydroxycarbamide as prevention for severe pain episodes among sickle cell patients(Steinberg et al, 2003), vary by genotype needs to be determined.